Cargando…

The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI): A series of four guidance documents for academics, drug regulators and industry partners

Detalles Bibliográficos
Autores principales:	Corris, Paul A, Nikkho, Sylvia, Fernandes, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682221/ https://www.ncbi.nlm.nih.gov/pubmed/33282191 http://dx.doi.org/10.1177/2045894020963031

Ejemplares similares

The importance of deep phenotyping PH registries with a focus on the PVRI-GoDeep registry
por: Corris, Paul A
Publicado: (2020)

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
por: Kiely, David G., et al.
Publicado: (2019)

IDDI: integrated domain-domain interaction and protein interaction analysis system
por: Kim, Yul, et al.
Publicado: (2012)

Remembering Almaz Aldashev: one of the founders of the PVRI
por: Butrous, Ghazwan
Publicado: (2017)

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
por: Nathan, Steven D., et al.
Publicado: (2022)

5(th) Scientific Workshops and Debates of the Pulmonary Vascular Research Institute (PVRI) Cape Town, South Africa 7-10 February, 2012
Publicado: (2011)

Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011
por: Lammers, Astrid E., et al.
Publicado: (2011)

Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
por: Nikkho, Sylvia, et al.
Publicado: (2020)

How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
por: Furlong, Pat, et al.
Publicado: (2015)

The Wyss institute: A new model for medical technology innovation and translation across the academic‐industrial interface
por: Tolikas, Mary, et al.
Publicado: (2017)

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016)

A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011
por: del Cerro, Maria Jesus, et al.
Publicado: (2011)

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary Hypertension
por: Piccari, Lucilla, et al.
Publicado: (2023)

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension
por: Nikkho, Sylvia M., et al.
Publicado: (2022)

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”
por: de Vlieger, Jon S. B., et al.
Publicado: (2019)

Experience of an academic institute in importing a novel preclinical drug into India
por: Kumar, M. Praveen, et al.
Publicado: (2017)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Effectiveness guidance document (EGD) for Chinese medicine trials: a consensus document
por: Witt, Claudia M, et al.
Publicado: (2014)

Plotting Academic Innovation: A Content Analysis of Twenty Institutional Websites
por: Barger, Adam P., et al.
Publicado: (2021)

CHOT ACADEMIC PARTNER
por: Weech-Maldonado, Robert
Publicado: (2019)

Guidance for Genuine Collaboration: Insights from Academic, Tribal, and Community Partner Interviews on a New Research Partnership
por: Stampfer, Orly, et al.
Publicado: (2019)

Effectiveness guidance document (EGD) for acupuncture research - a consensus document for conducting trials
por: Witt, Claudia M, et al.
Publicado: (2012)

Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners
por: Baber, Ronny, et al.
Publicado: (2019)

Neuroethics guidance documents: principles, analysis, and implementation strategies
por: O’Shaughnessy, Matthew R, et al.
Publicado: (2023)

Resolving anaphoras for the extraction of drug-drug interactions in pharmacological documents
por: Segura-Bedmar, Isabel, et al.
Publicado: (2010)

Ethical principles for project collaboration between academic professionals or institutions and the biomedical industry
por: Riis, Povl
Publicado: (2012)

2178 Drug development core facilitates institutional collaboration and translational science innovation
por: Morse, Gene, et al.
Publicado: (2018)

Discharge Practices for COVID-19 Patients: Rapid Review of Published Guidance and Synthesis of Documents and Practices at 22 US Academic Medical Centers
por: Greysen, S. Ryan, et al.
Publicado: (2021)

Local government institutions in Ghana: Core partners in health and safety performance in the construction industry
por: Akomah, Benjamin Boahene, et al.
Publicado: (2023)

Time to inclusion in clinical guidance documents for non-oncological orphan drugs and biologics with expedited FDA designations: a retrospective survival analysis
por: Rodriguez, Ryan, et al.
Publicado: (2021)

The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development
por: Takebe, Tohru, et al.
Publicado: (2018)

CHOT INDUSTRY PARTNER
por: Cochran, Kenneth
Publicado: (2019)

Documentation Displaces Teaching in an Academic Emergency Department
por: Baugh, Joshua J., et al.
Publicado: (2020)

Institute for Child Guidance Studies
por: Richards, T. W.
Publicado: (1931)

Perioperative Coronavirus Vaccination—Timing and Implications: A Guidance Document
por: Merritt-Genore, HelenMari, et al.
Publicado: (2021)

Institutional profile: the national Swedish academic drug discovery & development platform at SciLifeLab
por: Arvidsson, Per I, et al.
Publicado: (2017)

Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
por: Apolone, G, et al.
Publicado: (2005)

Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell‐ and tissue‐based products regulatory policy in the United States?
por: Yano, Kazuo, et al.
Publicado: (2018)

Research Partnerships and Guidance in Academic Global Ophthalmology
por: Ehrlich, Joshua R., et al.
Publicado: (2023)

International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs
por: Pruimboom‐Brees, Ingrid M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p14d2jq3bi9e96opmqqiqhilns